167 related articles for article (PubMed ID: 21367750)
21. Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells.
Tisato V; Norcio A; Celeghini C; Milani D; Gonelli A; Secchiero P
Clinics (Sao Paulo); 2014 Jan; 69(1):68-74. PubMed ID: 24473562
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A
Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel.
Lin H; Li Z; Chen C; Luo X; Xiao J; Dong D; Lu Y; Yang B; Wang Z
PLoS One; 2011; 6(5):e20362. PubMed ID: 21655246
[TBL] [Abstract][Full Text] [Related]
25. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
26. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
Lizé M; Pilarski S; Dobbelstein M
Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022
[TBL] [Abstract][Full Text] [Related]
27. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
28. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
29. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
[TBL] [Abstract][Full Text] [Related]
30. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
31. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
[TBL] [Abstract][Full Text] [Related]
32. LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1/E2F3 pathway.
Ren J; Ding L; Xu Q; Shi G; Li X; Li X; Ji J; Zhang D; Wang Y; Wang T; Hou Y
Sci Rep; 2017 Apr; 7(1):749. PubMed ID: 28389657
[TBL] [Abstract][Full Text] [Related]
33. A correlation analysis of miRNA‑34a and its predicted target genes in leukemia.
Tang R; Li J; Yue M; Liu Z; Feng S; Tang S; Wang T
Mol Med Rep; 2014 Apr; 9(4):1283-8. PubMed ID: 24504520
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
Pulikkan JA; Dengler V; Peramangalam PS; Peer Zada AA; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
Blood; 2010 Mar; 115(9):1768-78. PubMed ID: 20029046
[TBL] [Abstract][Full Text] [Related]
35. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
36. Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples.
di Iasio MG; Addobbati R; Radillo O; Voltan R
Invest New Drugs; 2012 Aug; 30(4):1761-5. PubMed ID: 21626114
[No Abstract] [Full Text] [Related]
37. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
38. The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway.
Agnoletto C; Brunelli L; Melloni E; Pastorelli R; Casciano F; Rimondi E; Rigolin GM; Cuneo A; Secchiero P; Zauli G
Oncotarget; 2015 Feb; 6(4):2385-96. PubMed ID: 25544776
[TBL] [Abstract][Full Text] [Related]
39. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
40. Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.
Agnoletto C; Melloni E; Casciano F; Rigolin GM; Rimondi E; Celeghini C; Brunelli L; Cuneo A; Secchiero P; Zauli G
Oncotarget; 2014 Jun; 5(12):4347-60. PubMed ID: 24962518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
